Resources Case Studies Coding & Billing Implementation Tools Package Inserts Product Information Videos, Webinars, & Podcasts Select ProductPlateletsAll ProductsIFCPlasmaPlateletsPRPCRSelect Resource TypeAll Resource TypesCase StudiesCoding & BillingImplementation ToolsPackage InsertsProduct InformationVideos, Webinars, & PodcastsUINTERCEPT Goes Beyond – Platelets and IFCINTERCEPT Blood System for PlateletsINTERCEPT Platelets Publications ListINTERCEPT Blood System Mechanism of ActionAssessing Platelet Availability – PR vs. LVDSUse of PR Platelets for Patient Safety and SustainabilityOptimizing Platelet Availability and Access to 100% PR InventoryVersiti PR Scale-UpUS Tertiary Care Hospital Gains Operational Efficiency and Fresher PlateletsImplementation of PR at Puerto Rico Blood Center During Zika OutbreakStanford Blood Center Implements 100% PRISBT Platelets CodesPlatelets and Plasma Outpatient Information GuideBest Practices Platelet Handling Guide – HospitalsPR Platelets Implementation GuideSample Labels SheetSample SBAR SheetSample Tie Tags SheetNurse Training ModuleImplementing INTERCEPT Platelets – E-learning TestNurse Handout TemplatePlatelets Small Volume (SV) Semi-Integrated Set – INT2140BPlatelets Dual Storage (DS) Semi-Integrated Set – INT2540BPlatelets Large Volume (LV) Semi-Integrated Set – INT2240BPlatelets Dual Storage (DS) – INT2530BPlatelets Large Volume (LV) – INT2230BPlatelets Small Volume (SV) – INT2130BPR – Proactive Strategy for Blood Safety in Pandemic PreparationCMV Mitigation SheetMethodologies for Reducing the Risk of TA-GVHD from Platelet TransfusionsINTERCEPT Integrated Sets Specifications InsertINTERCEPT Semi-integrated Sets Specifications InsertPlatelets Safety and Efficacy Technical SheetINTERCEPT Platelets Interview: Dr. Shannon Walker – Vanderbilt University Medical CenterINTERCEPT Platelets Interview: Dr. Deva Sharma – Vanderbilt University Medical CenterLogistical Management of Incorporating Pathogen Reduced Platelets into Inventory – Yale New-Haven HospitalThe Effects of PAS and PR on Platelet Use – Roswell Park Cancer InstituteComparing Useable Shelf-life of PR Platelets vs LVDS Screened Platelets – OneBloodPhased Implementation of Pathogen-Reduced Platelets – UCSDPlatelets Economic Model – RutgersImpact of PR vs LVDS Testing on Platelet Availability2022 AABB Abstract Book2023 AABB Abstract BookSeptic Transfusion Reaction AwarenessUpdating a Software Model to Estimate the Cost and Shelf Life Implications of New Platelet TechnologiesImplementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Johns Hopkins All Children’s Hospital)Implementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Allegheny Health Network)Evaluating Usable Shelf-Life of Pathogen Reduced and LVDS Tested Platelet ComponentsAssessing Platelet Availability from Blood Center and Hospital PerspectivesReview of Neonate to Pediatric Patient Outcomes Transfused with Amotosalen/UVA Treated PlateletsPathogen Reduction of Platelets: Patient Safety and FDA Platelet Bacterial Guidance CompliancePathogen Reduction of Platelets: Guidance Compliance and ImplementationPreparing Our Blood Supply for the Next Pandemic with Dr. Susan StramerHemostatic Efficacy of Pathogen Reduced Platelets in Pediatric Cardiopulmonary BypassImplementing Pathogen Reduced (PR) INTERCEPT Platelets and Pediatric ConsiderationsPathogen Reduced Platelet Implementation at Stanford HospitalPlatelet Component Bacterial Risk Control: An Evolution in ProgressPlatelet Pathogen Reduction Technology Implementation at Stanford Blood CenterThe Rationale for Pathogen Reduction: Blood Center and Transfusion Services PerspectivesImpact of Anaerobic Culture of Platelets on Safety and OperationsMerits and Pitfalls of Automated Bacterial Culture Methods in Improving Bacterial Safety of Platelet ConcentratesImpact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER Study
Logistical Management of Incorporating Pathogen Reduced Platelets into Inventory – Yale New-Haven Hospital
Updating a Software Model to Estimate the Cost and Shelf Life Implications of New Platelet Technologies
Implementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Johns Hopkins All Children’s Hospital)
Implementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Allegheny Health Network)
Merits and Pitfalls of Automated Bacterial Culture Methods in Improving Bacterial Safety of Platelet Concentrates
Impact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER Study